Pharmaceuticals: Major
Italian companies operating in the same pharmaceuticals: major industry
The table below has Italian companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Recordati S.p.A.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 4LLYEli Lilly and Company | 990.15 B EUR | 1,053.0 EUR | +0.94% | 0 | 0.00 | 43.79 | 24.05 EUR | +115.50% | 0.54% | Health technology | Buy |
| 1LLYEli Lilly and Company | 990.15 B EUR | 1,052.4 EUR | +0.98% | 251 | 1.00 | 43.77 | 24.05 EUR | +115.50% | 0.54% | Health technology | Buy |
 1JNJJohnson & Johnson | 558.01 B EUR | 231.10 EUR | +1.12% | 198 | 0.89 | 30.59 | 7.55 EUR | −4.82% | 1.99% | Health technology | Buy |
| 4JNJJohnson & Johnson | 558.01 B EUR | 230.95 EUR | +1.07% | 0 | 0.00 | 30.57 | 7.55 EUR | −4.82% | 1.99% | Health technology | Buy |
 1ABBVAbbVie, Inc. | 402.82 B EUR | 227.7 EUR | +0.31% | 0 | 0.00 | 129.75 | 1.75 EUR | −19.05% | 2.60% | Health technology | Buy |
| 4ABBVAbbVie, Inc. | 402.82 B EUR | 227.6 EUR | +0.35% | 0 | 0.00 | 129.70 | 1.75 EUR | −19.05% | 2.60% | Health technology | Buy |
 1ROGRoche Holding Ltd | 304.55 B EUR | 376.35 EUR | +0.04% | 70 | 3.95 | 22.67 | 16.60 EUR | +32.10% | 2.76% | Health technology | Buy |
| 1RORoche Holding Ltd | 304.55 B EUR | 385.6 EUR | +0.84% | 66 | 1.00 | 23.23 | 16.60 EUR | +32.10% | 3.00% | Health technology | Buy |
 4MRKXMerck & Co., Inc. | 284.57 B EUR | 115.26 EUR | +1.60% | 50 | 10.64 | 37.48 | 3.08 EUR | −51.56% | 2.56% | Health technology | Buy |
| 1MRKXMerck & Co., Inc. | 284.57 B EUR | 114.72 EUR | −0.19% | 0 | 0.00 | 37.30 | 3.08 EUR | −51.56% | 2.56% | Health technology | Buy |
 1NOVNNovartis AG | 249.27 B EUR | 136.48 EUR | −0.32% | 3.3 K | 0.77 | 23.97 | 5.69 EUR | −10.40% | 2.92% | Health technology | Neutral |
 4PFEPfizer Inc. | 122.95 B EUR | 21.625 EUR | −3.16% | 0 | 0.00 | 19.16 | 1.13 EUR | −11.40% | 7.01% | Health technology | Neutral |
| 1PFEPfizer Inc. | 122.95 B EUR | 21.630 EUR | −0.55% | 1.5 K | 0.34 | 19.16 | 1.13 EUR | −11.40% | 7.01% | Health technology | Neutral |
 1BMYBristol-Myers Squibb Company | 111.46 B EUR | 54.64 EUR | +0.63% | 10 | 0.17 | 17.72 | 3.08 EUR | +25.24% | 4.03% | Health technology | Buy |
| 4BMYBristol-Myers Squibb Company | 111.46 B EUR | 54.60 EUR | +0.50% | 0 | — | 17.71 | 3.08 EUR | +25.24% | 4.03% | Health technology | Buy |
 4VRTXVertex Pharmaceuticals Incorporated | 106.51 B EUR | 421.10 EUR | +0.62% | 0 | — | 28.84 | 14.60 EUR | — | 0.00% | Health technology | Buy |
| 1VRTXVertex Pharmaceuticals Incorporated | 106.51 B EUR | 421.20 EUR | +0.68% | 3 | 0.29 | 28.85 | 14.60 EUR | — | 0.00% | Health technology | Buy |
 4SANSanofi SA | 91.68 B EUR | 76.18 EUR | +0.22% | 0 | — | 17.90 | 4.26 EUR | −3.87% | 5.42% | Health technology | Buy |
| 1SANSanofi SA | 91.68 B EUR | 76.12 EUR | +0.05% | 978 | 0.76 | 17.89 | 4.26 EUR | −3.87% | 5.42% | Health technology | Buy |
 4MRKMerck KGaA | 60.5 B EUR | 139.90 EUR | +0.32% | 0 | — | 24.02 | 5.82 EUR | −10.15% | 1.58% | Health technology | Buy |
| 1MRKMerck KGaA | 60.5 B EUR | 139.85 EUR | +0.32% | 15 | 0.20 | 24.01 | 5.82 EUR | −10.15% | 1.58% | Health technology | Buy |
 4REGNRegeneron Pharmaceuticals, Inc. | 60.46 B EUR | 582.3 EUR | +1.18% | 0 | 0.00 | 16.39 | 35.52 EUR | −2.18% | 0.55% | Health technology | Buy |
| 1REGNRegeneron Pharmaceuticals, Inc. | 60.46 B EUR | 582.7 EUR | +1.25% | 0 | 0.00 | 16.40 | 35.52 EUR | −2.18% | 0.55% | Health technology | Buy |
 4UCBUCB S.A. | 46.74 B EUR | 246.0 EUR | +1.69% | 0 | — | 30.66 | 8.02 EUR | +46.56% | 0.41% | Health technology | Buy |
 4BAYNBayer AG | 45.25 B EUR | 46.12 EUR | −0.24% | 375 | 4.66 | — | −2.19 EUR | +33.72% | 0.24% | Health technology | Buy |
| 1BAYNBayer AG | 45.25 B EUR | 46.10 EUR | −0.86% | 11.12 K | 0.52 | — | −2.19 EUR | +33.72% | 0.24% | Health technology | Buy |
 1GALDGalderma Group AG | 43.88 B EUR | 193 EUR | +4.89% | 0 | 0.00 | 61.35 | 3.15 EUR | +113.32% | 0.20% | Health technology | Buy |
 1ALNYAlnylam Pharmaceuticals, Inc | 31.9 B EUR | 239.2 EUR | +2.31% | 0 | 0.00 | 65.67 | 3.64 EUR | — | 0.00% | Health technology | Buy |
 4ZTSZoetis, Inc. Class A | 27.77 B EUR | 66.24 EUR | +1.22% | 0 | — | 12.68 | 5.22 EUR | +1.50% | 2.73% | Health technology | Buy |
| 1ZTSZoetis, Inc. Class A | 27.77 B EUR | 66.16 EUR | +1.07% | 165 | 1.82 | 12.66 | 5.22 EUR | +1.50% | 2.73% | Health technology | Buy |
 4BIIBBiogen Inc. | 26.24 B EUR | 177.84 EUR | −0.39% | 0 | 0.00 | 22.05 | 8.07 EUR | −13.83% | 0.00% | Health technology | Buy |
| 1BIIBBiogen Inc. | 26.24 B EUR | 178.02 EUR | −0.25% | 0 | 0.00 | 22.07 | 8.07 EUR | −13.83% | 0.00% | Health technology | Buy |
 1INCYIncyte Corporation | 20.67 B EUR | 103.40 EUR | +0.58% | 240 | 10.26 | 16.89 | 6.12 EUR | +1,948.79% | 0.00% | Health technology | Buy |
| 4INCYIncyte Corporation | 20.67 B EUR | 103.35 EUR | +0.49% | 0 | 0.00 | 16.89 | 6.12 EUR | +1,948.79% | 0.00% | Health technology | Buy |
 1INSMInsmed Incorporated | 20.37 B EUR | 93.52 EUR | −0.26% | 0 | 0.00 | — | −4.97 EUR | +9.57% | 0.00% | Health technology | Strong buy |
 4VTRSViatris, Inc. | 17.79 B EUR | 15.166 EUR | +1.53% | 0 | — | — | −0.22 EUR | +92.37% | 2.78% | Health technology | Buy |
| 1VTRSViatris, Inc. | 17.79 B EUR | 15.194 EUR | +1.70% | 0 | 0.00 | — | −0.22 EUR | +92.37% | 2.78% | Health technology | Buy |
 1SOBISwedish Orphan Biovitrum AB | 14.16 B EUR | 41.42 EUR | −0.67% | 0 | 0.00 | 119.64 | 0.35 EUR | −69.23% | 0.00% | Health technology | Buy |
 1JAZZJazz Pharmaceuticals Public Limited Company | 14.02 B EUR | 221.3 EUR | −0.41% | 0 | 0.00 | — | −0.02 EUR | −100.23% | 0.00% | Health technology | Buy |
 1EXELExelixis, Inc. | 12.23 B EUR | 48.795 EUR | −0.29% | 0 | 0.00 | 18.69 | 2.61 EUR | +28.17% | 0.00% | Health technology | Buy |
 1MDGLMadrigal Pharmaceuticals, Inc. | 11.04 B EUR | 478.5 EUR | −0.02% | 0 | 0.00 | — | −11.08 EUR | +33.58% | 0.00% | Health technology | Strong buy |
 1ORNBVOrion Oyj Class B | 11.03 B EUR | 78.65 EUR | +0.45% | 0 | 0.00 | 18.85 | 4.17 EUR | +55.11% | 2.19% | Health technology | Buy |
| 4ORNBVOrion Oyj Class B | 11.03 B EUR | 78.50 EUR | −0.51% | 0 | 0.00 | 18.82 | 4.17 EUR | +55.11% | 2.19% | Health technology | Buy |
 RECRecordati S.p.A. | 10.6 B EUR | 51.35 EUR | 0.00% | 260.29 K | 1.06 | 22.77 | 2.26 EUR | +12.81% | 2.61% | Health technology | Buy |
 1CORTCorcept Therapeutics Incorporated. | 9 B EUR | 83.44 EUR | −0.69% | 400 | 52.63 | 275.44 | 0.30 EUR | −71.55% | 0.00% | Health technology | Strong buy |
 1CYTKCytokinetics, Incorporated | 8.83 B EUR | 71.62 EUR | −1.57% | 0 | 0.00 | — | −5.92 EUR | −20.70% | 0.00% | Health technology | Strong buy |
 1IONSIonis Pharmaceuticals, Inc. | 8.22 B EUR | 50.00 EUR | +0.26% | 0 | 0.00 | — | −1.82 EUR | +34.02% | 0.00% | Health technology | Strong buy |
 1TGTXTG Therapeutics, Inc. | 7.54 B EUR | 48.0 EUR | +2.56% | 0 | — | 19.33 | 2.48 EUR | +1,001.19% | 0.00% | Health technology | Strong buy |
 1RGENRepligen Corporation | 6.55 B EUR | 117.60 EUR | −1.55% | 0 | 0.00 | 149.57 | 0.79 EUR | — | 0.00% | Health technology | Strong buy |
 1GRFGrifols, S.A. Class A | 5.8 B EUR | 9.390 EUR | −3.36% | 0 | 0.00 | 15.38 | 0.61 EUR | +112.68% | 1.95% | Health technology | Buy |
| 4GRFGrifols, S.A. Class A | 5.8 B EUR | 9.602 EUR | +2.08% | 0 | — | 15.73 | 0.61 EUR | +112.68% | 1.95% | Health technology | Buy |
 1VKTXViking Therapeutics, Inc. | 3.55 B EUR | 30.55 EUR | −4.08% | 0 | 0.00 | — | −3.59 EUR | −237.07% | 0.00% | Health technology | Strong buy |
 4OGNOrganon & Co. | 3.12 B EUR | 11.896 EUR | −0.12% | 0 | — | 14.64 | 0.81 EUR | −69.58% | 0.59% | Health technology | Neutral |
| 1OGNOrganon & Co. | 3.12 B EUR | 11.896 EUR | −0.13% | 0 | — | 14.64 | 0.81 EUR | −69.58% | 0.59% | Health technology | Neutral |
 1ROVILaboratorios Farmaceuticos Rovi, S.A. | 2.97 B EUR | 58.55 EUR | +0.34% | 0 | — | 16.17 | 3.62 EUR | +39.34% | 1.29% | Health technology | Buy |
 1SRPTSarepta Therapeutics, Inc. | 1.46 B EUR | 13.86 EUR | −0.14% | 200 | 0.74 | — | −0.83 EUR | +64.97% | 0.00% | Health technology | Neutral |
 PHILPhilogen SpA | 676.97 M EUR | 23.15 EUR | +0.65% | 14.91 K | 0.66 | 4.06 | 5.70 EUR | +407.11% | 3.02% | Health technology | Strong buy |
 FFFine Foods & Pharmaceuticals N.T.M. SpA | 201.41 M EUR | 8.24 EUR | −3.06% | 32.71 K | 1.06 | 29.25 | 0.28 EUR | −26.43% | 1.94% | Health technology | Buy |
 4IPHInnate Pharma SA Class A | 149.12 M EUR | 1.582 EUR | −0.13% | 0 | — | — | −0.54 EUR | +11.11% | 0.00% | Health technology | Buy |